Learn more

ANVAR

Overview
  • Total Patents
    4,013
About

ANVAR has a total of 4,013 patent applications. Its first patent ever was published in 1967. It filed its patents most often in France, United States and Germany. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and machines are RESEARCH CORP, PROCEPT INC and INST RECH SCIENT.

Patent filings per year

Chart showing ANVARs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Chedid Louis 101
#2 Lefrancier Pierre 76
#3 Audibert Francoise 74
#4 Lederer Edgar 67
#5 Choay Jean 57
#6 Potier Pierre 33
#7 Parant Monique 29
#8 Jolles Pierre 28
#9 Langlois Yves 24
#10 Petit Jean-Francois 22

Latest patents

Publication Filing date Title
FR2623031A2 Improved device for adjusting energy exchanges between generator and / or receiver electrical systems
FR2598803A1 Device for measuring the intensity of a radiative flow
FR2590091A1 Electronic static switching device with controllable lock
FR2585196A1 STATIC DEVICE FOR ADJUSTING ENERGY EXCHANGES BETWEEN GENERATOR AND / OR RECEIVER ELECTRICAL SYSTEMS
FR2583049A1 Products resulting from the conjugation of a macromolecular support, a haptena and a muramyl-peptide through a group substituting the saccharidic part of muramyl-peptide and selectively immunogenic compositions containing these products
FR2581069A1 Type 2- glycopeptides (2-acetamido-2-desoxy-3-o-d-glucopyranosyl) -alcanoyl-aminoacyl-nor leucin or derivatives of such glycopeptides and immunoadjuvant compositions containing them
WO8503408A1 Light and luminous utilitarian buildings and construction method
FR2569984A1 Synthetic molecule containing a plurality of separate epitopes, process for obtaining same and application to the production of polyvaccines
IE841973L Vaccine compositions containing a haptene (-oligomer)
FR2564662A1 Steering interface of an electronic static switch of the commandable type
FR2564096A1 Lipophilic derivatives of muramylpeptides having macrophage activation properties, compositions containing them and process for obtaining the same
FR2566175A1 Electron multiplier device, located by the electric field
FR2558165A1 Novel conjugates of oligo-muramylpeptides and biological compositions containing them for the activation of macrophages
EP0104109A1 Plasma torches
FR2551758A1 Muramyl-peptides and steroid derivatives having macrophage activation properties
FR2550203A1 Synthetic immunogenic peptides carrying a characteristic epitope of the hepatitis b virus surface antigen and compositions containing them
FR2550094A1 Vaccine compositions conditioned for the vaccination of immunitary non-native subjects against a determined pathogenic agent and containing a haptena which includes a characteristic antigenic site of said pathogenic agent or an oligomer of this hapten
CA1203479A Process of separating or purifying a sleep promoting factor from a biological medium by an immunological reaction of the antigen-antibody type
EP0101121A1 Static electric energy conversion device with semiconductors
EP0101629A1 Static electric energy conversion unit with semiconductors